𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The comparative study on ultrastructure and immunohistochemistry in AFP negative and positive hepatocellular carcinoma

✍ Scribed by Zheng Meirong; Ruan Youbing; Yang Mulan; Guan Yang; Wu Zhongbi


Publisher
Springer-Verlag
Year
2004
Tongue
Chinese
Weight
479 KB
Volume
24
Category
Article
ISSN
0510-9752

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Chemical forms of metallothionein and ce
✍ Akihiro Nakayama; Riichi Tawa; Nobuyuki Masuyama; Masaaki Ebara; Hiroyuki Fukuda πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 165 KB πŸ‘ 1 views

## Abstract Metallothionein (MT) has been described as a cell‐protective protein that binds several heavy metals. In mammals, MT plays an important physiological role that includes detoxifying heavy metals, accumulating essential trace elements in cells to maintain homeostasis, and scavenging react

Transcatheter oily chemoembolization in
✍ Denis Vetter; Jean-Jacques Wenger; Jean-Michel Bergier; Michel Doffoel; RenΓ© Boc πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 836 KB

Transcatheter oily chemoembolization is widely used as palliative therapy for inoperable hepatocellular carcinoma in high-incidence Asiatic areas. To assess its usefulness in the Western form of this cancer, 30 French patients were treated between 1987 and 1990 by intraarterial hepatic injection of

Field-practice study of sorafenib therap
✍ Massimo Iavarone; Giuseppe Cabibbo; Fabio Piscaglia; Claudio Zavaglia; Antonio G πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 229 KB πŸ‘ 2 views

on behalf of the SOFIA (SOraFenib Italian Assessment) study group A multicenter randomized controlled trial established sorafenib as a standard of care for patients with advanced hepatocellular carcinoma (HCC). Because the study was prematurely interrupted due to survival benefits in the sorafenib a